Section Arrow
CTSO.NASDAQ
- Cytosorbents Corp
(Financial Status)
Quotes are at least 15-min delayed:2026/04/27 08:04 EDT
Pre Market
Last
 --
-- (--)
Bid
0.5705
Ask
0.73
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 0.6282
-0.0197 (-3.04%)
Day High 
0.65 
Prev. Close
0.6479 
1-M High
0.75 
Volume 
22.06K 
Bid
0.5705
Ask
0.73
Day Low
0.615 
Open
0.64 
1-M Low
0.4992 
Market Cap 
40.69M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.62 
20-SMA 0.6 
50-SMA 0.66 
52-W High 1.39 
52-W Low 0.4992 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.13/-0.06
Enterprise Value
69.26M
Balance Sheet
Book Value Per Share
0.09
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
37.06M
Operating Revenue Per Share
0.48
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITOCiTonic Holdings Ltd.0.374+0.0744+24.83%-- 
Pre Market 0.3434 -0.0306 -8.18%
BSXBoston Scientific Corp62.07-3.62-5.51%33.94PE
Pre Market 62.1 +0.03 +0.05%
ABTAbbott Laboratories91.13-1.35-1.46%24.75PE
Pre Market 91.25 +0.12 +0.13%
EWEdwards Lifesciences Corp84.15+4.43+5.56%45.45PE
Pre Market 83.5 -0.65 -0.77%
PACBPacific Biosciences of California1.56-0.01-0.64%-- 
Pre Market 1.56 0 0.00%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.